Thank you, Mr. Chair.
I thank all the witnesses for their testimony.
My questions will be mainly for Ms. Langlois.
Ms. Langlois, I would like to talk about the letter that you sent to several parliamentarians on March 23, sharing your concerns about an amendment to the TRIPS agreement.
The second point you mentioned is that, according to the current draft, only countries producing less than 10% of global vaccines would be eligible. Would it not be more appropriate, for example, to also allow countries that produce more than 10% of global vaccine to participate, on condition that they produce vaccines for lower-income countries?
Could you talk about that, please?